Sorrento Therapeutics had a revenue of 15.03M in the quarter ending Jun 30, 2023, with -7.54%. This bring the company's revenue in the last twelve months to 64.27M, Decreased 5.87%. In the fiscal year ending Dec 31, 2022, Sorrento Therapeutics had annual revenue of 62.84M with 18.78% growth.